Diagnos Inc.
TSX VENTURE : ADK

Diagnos Inc.

October 16, 2009 14:30 ET

DIAGNOS Inc.: Clarification of Previously Issued Press Release Dated October 5th, 2009

BROSSARD, QUEBEC--(Marketwire - Oct. 16, 2009) - With reference to a press release dated October 5th, 2009, DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), would like to re-iterate and clarify that the bilateral Memorandum of Understanding signed on October 1st, 2009 is between DIAGNOS Inc., and Carl Zeiss Canada Ltd, as stated in the press release.

With reference to the same press release, DIAGNOS would like to correct that Carl Zeiss Canada Ltd, is a Canadian legal entity wholly owned by Carl Zeiss AG engaged in the medical sales and service of Carl Zeiss Meditec medical and scientific equipment, and not a Canadian subsidiary of Carl Zeiss Meditec as previously communicated.

Under the terms of the Memorandum of Understanding between DIAGNOS and Carl Zeiss Canada Ltd, the two parties will work together to assure compatibility between DIAGNOS' Computer Assisted Retinal Analysis (CARA) technology and Zeiss' fundus camera and associated imaging software VisuPac, as well as jointly engage in pilot projects aimed at testing the integrated Carl Zeiss Canada Ltd, / DIAGNOS offering in the Canadian marketplace.

This update does not change any other terms to the underlying Memorandum of Understanding and any other information reported with respect to the relationship.

About Carl Zeiss Canada Ltd

Carl Zeiss Canada Ltd was founded in 1963 with the scientific division selling and servicing laboratory and surgical microscopes and related products. In 1979 the optical division was added to supply Zeiss eye glasses to the Canadian market. By 1992, the optical division had grown into a full service optical lab with lens surfacing and coating capabilities. In 2002, Carl Zeiss Canada expanded further by reintroducing the Carl Zeiss Meditec line of ophthalmic diagnostic equipment to its medical sales and service group.

About DIAGNOS

Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX: ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision-making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare, natural resources, and entertainment.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.

Contact Information